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ABSTRACT This study investigates how changes in the level of cellular cholesterol affect inwardly rectifying K1 channels
belonging to a family of strong rectiﬁers (Kir2). In an earlier study we showed that an increase in cellular cholesterol suppresses
endogenous K1 current in vascular endothelial cells, presumably due to effects on underlying Kir2.1 channels. Here we show
that, indeed, cholesterol increase strongly suppressed whole-cell Kir2.1 current when the channels were expressed in a null cell
line. However, cholesterol level had no effect on the unitary conductance and only little effect on the open probability of the
channels. Moreover, no cholesterol effect was observed either on the total level of Kir2.1 protein or on its surface expression.
We suggest, therefore, that cholesterol modulates not the total number of Kir2.1 channels in the plasma membrane but rather
the transition of the channels between active and silent states. Comparing the effects of cholesterol on members of the Kir2.x
family shows that Kir2.1 and Kir2.2 have similar high sensitivity to cholesterol, Kir2.3 is much less sensitive, and Kir2.4 has an
intermediate sensitivity. Finally, we show that Kir2.x channels partition virtually exclusively into Triton-insoluble membrane
fractions indicating that the channels are targeted into cholesterol-rich lipid rafts.
INTRODUCTION
Inwardly rectifying K1 (Kir) channels are known to play
critical roles in the maintenance of the membrane potential
and K1 homeostasis, which in turn regulate the excitability
of muscle cells and neurons (Hille, 1992; Lopatin and
Nichols, 2001). Downregulation of the Kir current was
shown to be associated with heart failure (Beuckelmann
et al., 1993). Consistent with these observations, reduction of
Kir2.1 current in guinea pigs by a dominant-negative Kir2.1
caused a prolonged QT interval and arrhythmia (Miake et al.,
2003). Targeted disruption of Kir2.1 in mice showed that
these channels are essential for K1-induced dilation of ce-
rebral arteries (Zaritsky et al., 2000). Furthermore, it was
shown recently that mutations in Kir2.1 cause Andersen’s
syndrome, an autosomal dominant disorder that is charac-
terized by cardiac arrhythmias, periodic paralysis, and dys-
trophic bone structure, as well as several developmental
abnormalities (Hosaka et al., 2003; Jongsma and Wilders,
2001; Lange et al., 2003; Plaster et al., 2001).
Currently, there are four known members of the Kir2
subfamily (Kir2.1–2.4). Kir2.1–2.3 channels are ubiqui-
tously expressed in a variety of tissues, including cardiac
cells (Melnyk et al., 2002; Miake et al., 2003; Wang et al.,
1998; Zobel et al., 2003), vascular smooth muscle cells
(Karkanis et al., 2003; Sampson et al., 2003; Zaritsky et al.,
2000), and neurons (as reviewed by Neusch et al., 2003),
whereas Kir2.4 expression appears to be tissue-speciﬁc
(Pruss et al., 2003; Topert et al., 1998). Although strong
rectiﬁcation and high constitutive activity are the general
biophysical properties of all Kir2.x channels, the channels
differ signiﬁcantly in their unitary conductances and sen-
sitivity to Ba21 block (Kubo et al., 1993; Liu et al.,
2001; Makhina et al., 1994; Perier et al., 1994; Schram et al.,
2003; Takahashi et al., 1994; Topert et al., 1998). There is
also growing evidence that Kir2.x subunits may form func-
tional heterotetramers with intermediate properties (Preisig-
Muller et al., 2002; Schram et al., 2002, 2003; Zobel et al.,
2003).
Two major factors that are known to regulate Kir2
channels are protein phosphorylation (Tong et al., 2001;
Wischmeyer et al., 1998; Wischmeyer and Karschin, 1996;
Zhu et al., 1999) and interaction with phosphoinositides
(Huang et al., 1998; Soom et al., 2001; Zhang et al., 1999),
major lipid second messengers (reviewed by McLaughlin
et al., 2002, and Yin and Janmey, 2003). Our recent studies
have suggested that Kir2 channels may also be regulated by
the level of membrane cholesterol (Romanenko et al., 2002),
a major structural component of the plasma membrane that
may constitute up to 40 mol % of membrane lipids (Yeagle,
1991). Speciﬁcally, we have shown that enriching aortic
endothelial cells with cholesterol signiﬁcantly suppresses
inwardly rectifying K1 current, whereas cholesterol de-
pletion enhances the current (Romanenko et al., 2002). Since
endothelial Kir current has strong rectiﬁcation that is a known
characteristic feature of the Kir2 channels and since several
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studies have reported that aortic endothelial cells express
Kir2.1 (Eschke et al., 2002; Forsyth et al., 1997; Kamouchi
et al., 1997; Yang et al., 2003), we have proposed that Kir2.1
channels are sensitive to membrane cholesterol. In this study,
we test this hypothesis directly by testing cholesterol sensi-
tivity of the Kir2.1, as well as other Kir2.x channels ex-
pressed in a null cell line that has virtually no endogenous
Kir current. We show that not only Kir2.1 but all four Kir2.x
channels are cholesterol-sensitive; however, they display
signiﬁcant differences in the degree of their cholesterol sen-
sitivity. We also show that, consistent with the sensitivity of
the channels to cholesterol, Kir2 channels partition into the
Triton-insoluble membrane fractions.
MATERIALS AND METHODS
Channel expression and cell culture
Chinese hamster ovary (CHO) K1 cell line was obtained from the laboratory
of Dr. Zhe Lu and maintained at 37C in a humidiﬁed 5% CO2 atmosphere
in Ham’s F-12 media (BioWhittaker, San Diego, CA) supplemented with
heat-inactivated 10% fetal bovine serum (Gemini BioProducts, Woodland,
CA). The cells were fed or split every 2–3 days.
Transfection protocols
Kir2.x constructs were cotransfected with enhanced green ﬂuorescent
protein (eGFP; cmv-pcDNA3.1-GFP-TOPO, Invitrogen, Carlsbad, CA)
using Lipofectamine (Gibco-BRL, Gaithersburg, MD) according to the
manufacturer’s instructions. Kir2.1 (mouse) and Kir2.2 (mouse) clones are
a gift of Dr. Kurachi, Osaka University, Japan; Kir2.4 construct (rat) is a gift
from Dr. Karschin, University of Wu¨rzburg, Germany; and HA-Kir2.1
(mouse) clone, tagged with an HA epitope inserted into the extracellular
M1-H5 loop (Dart and Leyland, 2001), is a gift from Dr. Caroline Dart,
University of Leicester, UK. All constructs were inserted into the cmv-
pcDNA3 vector.
Modulation of cellular cholesterol level
At 24 h after transfection, CHO cells were enriched with or depleted of
cholesterol by incubating them with methyl-b-cyclodextrin (MbCD)
saturated with cholesterol or with empty MbCD (not complexed with
cholesterol), as described previously (Levitan et al., 2000). Brieﬂy, a small
volume of cholesterol stock solution in chloroform:methanol (1:1, vol/vol)
was added to a glass tube and the solvent was evaporated. Then, 5 mM
MbCD solution in Ham’s F-12 medium without serum was added to the
dried cholesterol. The tube was vortexed, sonicated, and incubated overnight
in a shaking bath at 37C. MbCDwas saturated with cholesterol at a MbCD/
cholesterol molar ratio of 8:1, the saturation limit of MbCD (Christian et al.,
1997). In preparation for an experiment, cells were washed three times with
serum-free F-12 medium. Cells were then incubated with cholesterol-
saturated MbCD solution or with MbCD solution containing no cholesterol
(empty MbCD), or a mixture of these for 120 min. During the incubation,
cells were maintained in a humidiﬁed CO2 incubator at 37C. After exposure
to MbCD, cells were washed three times with serum-free medium and
returned to the incubator. Cells that were incubated in serum-free medium
maintained the elevated or the decreased level of cholesterol for at least 24 h,
providing the time window for the electrophysiological recordings. To
attain the intermediate cellular levels of cholesterol, cells were exposed to
various mixtures of 5 mM MbCD saturated with cholesterol and 5 mM
MbCD. MbCD and cholesterol were purchased from Sigma Chemical
(St. Louis, MO).
Measurement of cellular sterols
Lipid was extracted from the washed cell monolayer using isopropanol as
previously described (McCloskey et al., 1987). Total sterol mass analysis
was done by gas-liquid chromatography (GLC) as previously described
(Ishikawa et al., 1974; Klansek et al., 1995). Brieﬂy, before lipid extraction
the medium was removed and the cells were dried in air. Dried cells were
extracted with isopropanol containing a known amount of cholesteryl
methyl ether as an internal standard. After 4 h, the extracts were dried under
N2 at 35C, reextracted with tetrachloroethylene, dissolved in CS2, and
analyzed by GLC. Cell protein was determined on the lipid-extracted
monolayer using a modiﬁcation (Markwell et al., 1978) of the method of
Lowry (Lowry et al., 1951). All mass values were normalized on the basis of
cell protein.
Electrophysiological recording
Previously, we have shown that the onset of Kir current change is delayed
for 2–4 h after manipulating the membrane sterol composition (Romanenko
et al., 2002). Therefore, here we recorded the currents at least 4 h after the
end of treatment of cells with MbCD or its complexes.
Ionic currents were measured using whole-cell and cell-attached con-
ﬁgurations of the standard patch-clamp technique (Hamill et al., 1981).
Pipettes were pulled (SG10 glass, 1.20 mm ID, 1.60 mm; part # FPENNU
1.20ID1.60OD, Richland Glass, Richland, NJ) to give a ﬁnal resistance of
2–6MV. These pipettes generated high-resistance seals without ﬁre polishing.
A saturated salt agar bridge was used as reference electrode. Currents were
recorded using an EPC9 ampliﬁer (HEKA Electronik, Lambrecht, Germany)
and accompanying acquisition and analysis software (Pulse and PulseFit,
HEKA Electronik, Lambrecht, Germany).
Whole-cell recordings
The external recording solution contained (in mM) 150 NaCl, 6 KCl,
10 HEPES, 1.5 CaCl2, 1 MgCl2, and 1 EGTA, pH 7.3. The pipette solutions
contained (in mM) 145 KCl, 10 HEPES, 1 MgCl2, 4 ATP, and 1 EGTA,
pH 7.3. Current was monitored by 500-ms linear voltage ramps from 160
to160 mV at an interpulse interval of 5 s. Kir2 inactivation was determined
by using a two-pulse voltage protocol: 500-ms voltage pulses were applied
from180 to160 mVwith increments of 10 mV and immediately followed
by 10-ms test pulses to 160 mV. The holding potential for both protocols
was 60 mV. Pipette and whole-cell capacitances were automatically com-
pensated. Whole-cell capacitance and series resistance were compensated
and monitored throughout the recording. Rs was compensated by 60–90%,
with the compensation being limited by the stability of the patch.
Single-channel recordings
Pipettes were pulled to smaller diameter and had resistances of 7–9 MV.
Both the external recording and the pipette solutions contained (in mM) 156
KCl, 10 HEPES, 1.5 CaCl2, 1 MgCl2, 1 EGTA, pH 7.3. Channel activity
was recorded in 1.6-s sweeps with a 0.1-ms sampling interval and ﬁltered at
500 Hz. All experiments were performed at room temperature (22–25C).
The chemicals for the recording solutions were obtained from Fisher
Scientiﬁc (Fairlawn, NJ) or Sigma Chemical (St. Louis, MO). The osmo-
larities of all solutions were determined immediately before recording with
a vapor pressure osmometer (Wescor, Logan, UT) and were adjusted by the
addition of sucrose to attain isosmotic conditions.
To test if the inhibition of protein synthesis can affect the regulation of
Kir2.1 current by cholesterol, the cells were transfected with one of the
channel constructs, then, 24 h later, incubated overnight (12–18 h) with
5 mg/ml cycloheximide (CHX). Subsequently, the cells were treated for
cholesterol depletion and the currents were recorded $4 h later (all the
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solutions were supplemented with 5 mg/ml CHX). CHX was purchased from
Sigma and 5 mg/ml CHX aqueous stock solution was used.
Immunoblotting and immunostaining
For immunoblots, cells were transfected with Kir2.x subunits and exposed to
MbCD treatment, as described above, 24 h after the transfection. At 4 h after
the MbCD treatment, the cells (1–10106) were washed three times with ice-
cold phosphate-buffered solution (PBS) without Ca21 and Mg21. All the
following steps were carried out at 4C. For preparation of whole-cell
homogenate, washed cells were scraped into Laemmli buffer supplemented
with 1x protease inhibitor cocktail (PIC) (Roche, Indianapolis, IN) and
1 mg/ml pepstatin, and sonicated. Alternatively, cells were scraped into
Buffer A (in mM): 150 NaCl, 20 HEPES, 5 EDTA, pH 7.4, 1x PIC, 1 mg/ml
pepstatin; homogenized in a Dounce tissue grinder (40 strokes), and
centrifuged for 10 min at 10003 g. The pellet was resuspended in Buffer A,
dounced, and recentrifuged for 10 min at 1,0003 g. Combined supernatant
was centrifuged for 1 h at 200,000 3 g (SW40Ti rotor, Beckman Coulter,
Fullerton, CA). For preparation of total-membrane sample, the high-speed
pellet was resuspended in Laemmli buffer and sonicated. Alternatively, for
preparation of Triton-soluble and insoluble membrane fractions, the high-
speed pellet was resuspended in 1 ml of Buffer A, sonicated 3 3 10 s, and
supplemented with a small volume of concentrated solution of Triton X-100
to a ﬁnal concentration of 1%. After 15 min incubation on ice the suspension
was centrifuged for 1 h at 200,000 3 g. Then the pellet was resuspended in
Laemmli buffer. Sample total protein was measured using BCA Protein
Assay kit (BioRad, Hercules, CA). Samples (1–50 mg protein/lane, identical
amount per lane on a blot) were resolved with 12% SDS PAGE at reducing
conditions followed by transfer to polyvinylidene diﬂuoride membranes
(Amersham, Piscataway, NJ). The membranes were probed with either anti-
Kir2.x or anti-caveolin1 (BD Pharmingen, San Diego, CA). Bound primary
antibodies were detected using secondary antibodies conjugated with HRP
(Jackson Laboratories, West Grove, PA). Finally, immunoreactivity was
visualized with ECL Plus reagent (Amersham, Piscataway, NJ). Detected
bands were analyzed densitometrically using National Institutes of Health’s
ImageJ image processing program (available at http://rsb.info.nih.gov/ij/
docs/index.html).
Afﬁnity-puriﬁed rabbit anti-rat Kir2.2 polyclonal antibodies as pre-
viously described (Raab-Graham and Vandenberg, 1998) were generated to
a peptide (RTNRYSIVSSEEDGMKLA) corresponding to a stretch of 21
amino acids in the carboxyl terminus of rat Kir2.2 (residues 390–410).
Similarly, anti-rat Kir2.1 and Kir2.3 antibodies were made against amino
acid sequences 390–411 and 2–19 from corresponding channel proteins.
For immunostaining, cells were transfected with HA-Kir2.1 construct
and exposed to MbCD treatment, as described above, 48 h after the
transfection. At 4 h after the MbCD treatment, HA-Kir2.1 transfected cells
seeded on glass coverslips were ﬁxed with 4% paraformaldehyde. Cells were
then blocked (in PBS containing 1% bovine serum albumin (BSA) and 5%
goat serum) for 1 h, incubated with primary antibody (1:100 in PBS
containing 1% BSA and 5% goat serum) overnight, washed, incubated with
Alexa586-conjugated secondary antibody (1:200 dilution in PBS containing
1% BSA and 1% goat serum, 1 h), washed, mounted, and viewed using
a Zeiss Axiovert 100TV microscope (Zeiss, Jena, Germany). The primary
antibody used was rat monoclonal anti-HA Ab3F10 (Roche Diagnostics,
Germany) and the secondary antibody used was Alexa568-conjugated goat
anti-rat IgG (Molecular Probes, Eugene, OR).
ELISA assay
The protocol for the ELISA assay was similar to that used for
immunostaining with a few exceptions. Cells were seeded on glass cover-
slips in 24-well plates at a density of 2 3 105 cell/well, transfected, treated
with MbCD, ﬁxed, and incubated in primary antibody. Cells were then
incubated with horseradish peroxidase (HRP) conjugated secondary
antibody (1:200 dilution in PBS containing 1% BSA and 1% goat serum,
30 min) and washed in PBS containing 1% BSA and 1% goat serum, three
times for 5 min each; then in PBS, three times for 5 min each). ECL Plus
reagent (0.3 ml; Amersham, Piscataway, NJ) was then added to a well, and
after 10 s measurements were taken on a Fluoroskan Ascent FL
(Labsystems, Franklin, MA), with subsequent measurement taken every
30 s for a period of 2 min. The secondary antibody used was HRP-
conjugated goat anti-rat (Jackson Laboratories, West Grove, PA).
Microscopy
Fluorescent images were acquired using a Zeiss Axiovert 100TV
microscope with 633 Plan-Apochromat lens (NA 1.4), a precisely
controlled XYZ stage (Applied Precision, Issaquah, WA) and a scientiﬁc-
grade cooled charge-coupled device camera (MicroMax, Princeton Instru-
ments, Trenton, NJ). To create 3-D reconstructions of the cells, 20 optical
sections were attained at a distance of 300 nm apart along the z axis per cell.
Constrained iterative deconvolution and 3-D rendering were performed
using Deltavision software, Softworx (Applied Precision) on a 02 R10000
RISC workstation (Silicon Graphics, Mountain View, CA).
Analysis
Statistical analysis of the data was performed using a standard two-sample
Student’s t-test assuming unequal variances of the two data sets. Statistical
signiﬁcance was determined using a two-tail distribution assumption and
was set at 5% (p , 0.05).
For whole-cell recordings, to minimize the effect of capacitative artifact
at the beginning of the voltage steps, the peak currents were determined
14 ms after the beginning of voltage protocols. The degrees of rectiﬁcation
were quantiﬁed by ﬁtting voltage dependence of relative cord conductances
(Gc) with single Boltzmann function:Gc¼ 1/(11 exp((V V0.5)/k), where k
is the slope factor, V is the membrane potential, and V0.5 is the voltage of
half-maximal blocking. Relative chord conductance was deﬁned as the
conductance relative to that expected for an unrectiﬁed current (Shyng et al.,
1996). Channel conductances were determined as G ¼ (VM  V0)/Iinst,
where V0 is the calculated reversal potential and Iinst is the instantaneous
current measured upon introduction of the voltage step.
Reversal potentials were determined as the intersection of the current-
voltage relationship with the x axis. The liquid junction potentials for whole-
cell experiments were determined using the Junction Potential Calculator
in the pCLAMP package (Axon Instruments, Union City, CA) and used
for correction of determined reversal potentials. (Note that the recordings
presented at the ﬁgures were not corrected for the junction potential).
The time constants of voltage-dependent inactivation were measured by
ﬁtting to a single exponential function V(t) ¼ Aet/t where A is the current
amplitude and t is the time constant. The ﬁts were obtained with the
Levenberg-Marquardt algorithm using PulseFit software (HEKA Electro-
nik).
The slopes of current versus cholesterol relationships for Kir2.1 and
Kir2.3 channels were calculated from combined data (n ¼ 3–9 per
concentration) of daily averages of currents (n ¼ 3–7 cells per day) for each
of the cholesterol conditions. The cholesterol concentrations for each
condition were averaged (n ¼ 3–15). Analysis of covariance (test for
homogeneity of regression slopes) was used for comparison of linear
regression slopes (http://faculty.vassar.edu/lowry/VassarStats.html).
Single-channel amplitudes were determined using all-point histograms
and the unitary conductances were calculated from the slopes of the linear
ﬁts of the amplitudes measured at no fewer than three voltages between
140 and 60 mV. The open probabilities for recordings with multiple
channels present in the patch were calculated as Po ¼ I/(iN), where I is the
mean current of the patch, i is the average unitary channel current, and N is
the number of channels in the patch. Due to high open probability of the
channels, recordings with more than four channels were not analyzed.
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Single-channel events were analyzed using TAC/TACFit software (Bruxton,
Seattle, WA).
RESULTS
Kir2.1 is effectively regulated by
cellular cholesterol
To determine the effect of cholesterol on Kir2.1 channels, the
channels were heterologously expressed in CHO cells, a null
cell line that almost completely lacks inward K1 current (see
inset to Fig. 1 A). To identify successfully transfected cells,
Kir2.1 was coexpressed with a ﬂuorescent marker, GFP. As
expected, most of the ﬂuorescent cells that were cotrans-
fected (;80%) presented typical inwardly rectifying K1
currents (Fig. 1 A, upper traces) that were ;100-fold larger
than the background currents in untransfected cells or the
cells that were transfected with GFP alone. The reversal
potential of the currents was 82 6 3 mV (after correction
for the liquid junction potential; n¼ 12), close to the value of
the theoretical reversal potential for K1 current, which is
81 mV under the given recording conditions.
Cholesterol level in CHO cells was manipulated by
treating transfected cells with MbCD or MbCD saturated
with cholesterol (MbCD-cholesterol). Similar to our earlier
study in bovine aortic endothelial cells, exposing CHO cells
to MbCD resulted in an ;50% decrease in cellular choles-
terol, whereas exposing the cells to MbCD-cholesterol
resulted in;40% cholesterol enrichment (Fig. 1 B). Choles-
terol depletion caused an increase in the current density of
Kir2.1, whereas cholesterol enrichment resulted in current
suppression. It is important to note that Kir2.1 currents in
cholesterol-enriched cells were still;10-fold higher than the
background endogenous currents. The values of the reversal
potentials for the three experimental cell populations were
846 2 mV and816 3 mV for cholesterol-depleted cells
(n ¼ 7) and cholesterol-enriched cells (n ¼ 8), respectively,
similar to the value of the reversal potential in the untreated
cells. Mean current densities for the three experimental cell
populations are shown in Fig. 1 C. The inverse relationship
between the current densities and cellular cholesterol level
was not due to a change in the current rectiﬁcation properties
(Fig. 1 D) or changes in cell capacitance (13 6 1, 12 6 2,
and 156 1 pF for cholesterol-depleted, cholesterol-enriched,
and control cells, respectively). Fig. 2 shows that an increase
in cellular cholesterol had no effect on the unitary con-
ductance of the Kir2.1 channels and had a very small effect
on the channel openprobability, clearly insufﬁcient to account
for the observed decrease in the whole-cell Kir2.1 current.
Similarly, cholesterol enrichment also had no effect on the
hyperpolarization-induced inactivation of the whole-cell
Kir2.1 (Fig. 2, C–E).
FIGURE 1 Kir2.1 currents in cells
depleted of or enrichedwith cholesterol.
(A) Typical Kir2.1 current traces re-
corded from three individual cells:
a control cell that was exposed to
serum-free medium alone (upper fam-
ily); a cell depleted of cholesterol by
exposure to 5 mM MbCD (middle
family); and a cell that was enriched
with cholesterol by exposure to 5 mM
MbCD saturated with cholesterol
(lower family). Three superimposed
traces are shown for each cell. The
currents were elicited by 500 ms linear
voltage ramps from 160 mV to
160 mV, the ramps were applied with
intervals of 5 s for the duration of the
experiment. The holding potential be-
tween the rampswas60mV. The inset
shows the background current in a non-
transfected cell. (B) Cellular levels of
cholesterol after treatment as in A
measured by gas-liquid chromatogra-
phy. Cholesterol levels after treatment
of transfected and nontransfected cells
were not different (not shown;n¼ 9–15,
*P , 0.01). (C) Peak current densities
(160mV) of the three cell populations.
Three to seven cells were patched per
condition per day and the daily average was normalized to the same-day control. The bars represent the data pooled from 3–6 experimental days (*P, 0.01). (D)
Normalized current-voltage relationships at the three experimental conditions: (s), control cells; (n), cells treated with 5mMMbCD; and (:), cells treated with
5 mM MbCD-cholesterol (the symbols are mainly superimposed; n ¼ 4–7).
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Inhibition of protein synthesis does not abolish
the upregulation of Kir2.1 by cholesterol depletion
One possible mechanism of how changes in the level of
cholesterol might regulate Kir2.1 current would be regula-
tion of protein synthesis. To test this possibility, 24 h after
transfection with Kir2.1 and GFP the cells were incubated
with CHX, a widely-used nonspeciﬁc protein synthesis
inhibitor that has been shown to almost completely block
protein synthesis within 4–8 h (e.g., Nolop and Ryan, 1990;
Polunovsky et al. 1994). After overnight (12–18 h) exposure
to 5 mg/ml CHX, the average current density of Kir2.1
decreased ;2.5-fold, as determined by comparing CHX-
treated and control cells on the same day. As expected, when
the cells were transfected in the presence of CHX, GFP
ﬂuorescence was not observed. CHX had no apparent effect
on cell morphology or cell capacitance. The rectiﬁcation
of the Kir2.1 current was also unaffected, which was
determined by comparing voltage dependences of relative
cord conductances as described in Materials and Methods.
V0.5 was 82 6 2 mV (n ¼ 6) and 82 6 1 mV (n ¼ 4) for
control cells and CHX-treated cells, respectively, and the
slope factor (k) was 116 1 (n¼ 6) and 116 2 (n¼ 4) for the
cell populations. Fig. 3 shows that although exposure to
CHX decreased the amplitude of Kir2.1 current (Fig. 3 A),
cholesterol depletion still effectively upregulated the current
in CHX-treated cells (Fig. 3 B). Moreover, comparison of the
current densities normalized to respective controls recorded
on the same days showed that the sensitivity of Kir2.1 to
cholesterol depletion was unaffected by the inhibition of
protein synthesis.
Changes in cellular cholesterol have no effect
on total Kir2.1 protein level
To test further whether the sensitivity of Kir2.1 to cholesterol
involved regulation of the amount of Kir2.1 protein, the
FIGURE 2 Nominal effect of cholesterol on
Kir2.1 single-channel properties and whole-cell
current inactivation. (A) Typical single-channel
currents at different membrane potentials
recorded in the cell-attached conﬁguration
recorded in a control cell (a) and in a cell
treated with 5 mMMbCD-cholesterol (b). Bath
and pipette solutions contained 156 mM K1.
The currents were recorded at 0.1-ms sample
intervals and ﬁltered at 500 Hz. The closed
level is indicated by the arrow to the left of each
trace and the broken line. (Ba) I/V relationships
for the channels shown in A: (s), control cell;
(:), cell treated with 5 mM MbCD-choles-
terol. (Bb) Average unitary conductances
calculated from the slopes of the linear ﬁts
between 140 and 60 mV and (Bc) open
probabilities at 60 mV determined in control
and cholesterol-enriched cells (n ¼ 22–34,
*P , 0.05). (C) Typical Kir2.1 current traces
recorded from individual control and choles-
terol-enriched cells. A two-pulse voltage pro-
tocol was used: 500-ms voltage steps from
180 to 160 mV with increments of 10 mV
and immediately followed by 10-ms test pulses
to 160 mV. (D) Inactivation ratio (R) was
determined as the ratio of the current amplitude
in response to a test voltage pulse to that of
a160 mV test voltage pulse: (d), control cells;
(:), cells treated with 5 mM MbCD-choles-
terol (n ¼ 6–9). (E) Time constant of in-
activation (t) were plotted against voltage
(single exponential ﬁt): (d), control cells;
(:), cells treated with 5 mM MbCD-choles-
terol (n ¼ 8–9).
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levels of Kir2.1 protein were compared under different
cholesterol conditions using Western blot analysis. Kir2.1
proteins were probed with a polyclonal antibody raised
against rat Kir2.1. As expected, CHO cells transfected with
Kir2.1 presented a prominent band at ;50 kDa (Kir2.1
molecular mass predicted from its primary structure is 48),
whereas nontransfected CHO cells do not show this band. As
a demonstration of the speciﬁcity of this immunoreactivity,
the band disappeared after preabsorption of the antibody
with the antigen (Fig. 3 C). Fig. 3 D shows examples of blots
obtained by probing preparations of whole-cell homogenates
(a) or total membrane fractions (b) under different choles-
terol conditions. The intensities of the bands were similar in
cholesterol-depleted, cholesterol-enriched, and control cells.
Densitometric analysis of the bands shows no statistical
difference in Kir2.1 levels under the different cholesterol
conditions (Fig. 3 E). Since cholesterol depletion resulted in
rounding up of a small fraction of cells, a slight decrease in
the band density in cholesterol-depleted cells was likely to be
a consequence of the loss of cells during sample preparation.
Cholesterol level has no effect on surface
expression of Kir2.1
To determine whether changes in the level of cholesterol
affect the surface expression of Kir2.1 channels, the cells
were transfected with Kir2.1 subunits tagged with hemag-
glutinin (HA) epitope (YPYDVPDYA) on the extracellular
domain. The rationale of this approach is that the channels
that are inserted into the plasma membrane will have the tag
accessible for the anti-HA antibodies without permeabiliza-
tion of the membrane, whereas channels that reside in the
intracellular membranes will not. This method, therefore,
allows us to assess the surface expression of the channels
and to estimate whether cholesterol modulates the surface
expression of Kir2.1 channels. Two approaches were used
for quantiﬁcation of HA-Kir2.1 surface expression: 1), de-
convolution microscopy to estimate the surface expression of
the channels at a single-cell level (Fig. 4, A and B); and 2),
ELISA to measure the surface expression of the channels at
a cell population level (Fig. 4 C).
FIGURE 3 Cholesterol regulates
Kir2.1 after blocking protein synthesis
and does not affect Kir2.1 protein
expression. (A) Typical current traces
recorded from individual control cells
or cells treated with 5 mM MbCD. The
upper panel represents cells cultured in
full medium before cholesterol deple-
tion with MbCD and in serum-free
medium after the treatment. The lower
panel represents experiments for which
cells were treated similarly except that
all the media were supplemented with
5 mg/ml cycloheximide (1CHX) for
a total time of exposure to the protein
synthesis inhibitor of 18 h. (B) Mean
peak current densities in control cells
and cholesterol-depleted cells, which
were either exposed or not exposed to
CHX. The current densities were nor-
malized to the average of current
densities in control cells recorded on
the same experimental day (n ¼ 3 days,
with 3–5 cells per day per condition;
*P , 0.01 compared to respective
controls). (C) The speciﬁcity and sen-
sitivity of anti-Kir2.1 antibodies were
tested by probing the blots prepared
either from nontransfected cells or from
cells transfected with Kir2.1 cDNA.
Additionally, a separate blot was
probed with the antibodies preincu-
bated with the antigen. For each lane,
10 mg of total protein was loaded. (D)
An example of immunoblots of CHO
cells expressing Kir2.1 that were ex-
posed to serum-free medium, 5 mM
MbCD, or 5 mM MbCD saturated with cholesterol. The blots were prepared from either (a) whole-cell homogenates (12 mg of total protein per lane), or (b)
total membrane fraction (3 mg of total protein per lane). To avoid known saturating artifacts of high chemiluminescent signals, only the images that were well
below saturating levels were chosen for the quantiﬁcation. (E) Mean band densities of Kir2.1 immunoblots described in Da (n ¼ 4).
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Fig. 4 shows that neither cholesterol depletion nor
cholesterol enrichment had any signiﬁcant effect on the
HA-Kir2.1 surface expression. Typical images of optical
middle sections and of 3-D reconstructions composed of 20
individual sections each of nonpermeabilized CHO cells
under different cholesterol conditions are shown in Fig. 4 A,
panels a and b, respectively. No detectable ﬂuorescence was
observed in cells exposed to secondary antibodies only (not
shown). HA-speciﬁc ﬂuorescence appeared more clearly in
the edge of the cells, as compared to the top and bottom
surfaces, because imaging through the edges of rounded cells
provides better visualization of the cell sides. Fig. 4 B shows
that altering cell cholesterol level had no effect on HA-
speciﬁc ﬂuorescence of individual cells. Fluorescence was
quantiﬁed for the middle sections (Fig. 4 B, panel a) and for
the 3-D projections (Fig. 4 B, panel b), as well as for upper
and lower surface sections of the same cells (not shown).
Similar results were obtained in four independent experi-
ments.
To quantitatively determine the surface expression level of
Kir2.1 in cell populations (;3 3 105 cells/sample), HA-
Kir2.1 expression was quantiﬁed using an ELISA assay.
Consistent with the results obtained from the analysis of
individual cells, luminescence level measured in quadrupli-
cate samples per condition (Fig. 4 C) was similar at all
cholesterol levels in four independent experiments.
Comparison of cholesterol sensitivity of Kir2.1
with the other Kir2.x channels
The subfamily of Kir2 channels consists of four members,
Kir2.1–Kir2.4, whose homology differs between ;70% and
;50%. Therefore, we compared the inhibitory effect of
cholesterol on the four channels expressed in CHO cells. All
four channels were successfully expressed in the CHO cells
presenting typical inwardly rectifying K1 currents with the
predicted values of the reversal potentials (Fig. 5 A).
Although all Kir2.x were signiﬁcantly lower in cholesterol-
enriched cells in comparison with control cells, the degree of
the current decrease was different. Speciﬁcally, Kir2.1 and
Kir2.2 currents were strongly suppressed (;70% inhibition),
whereas Kir2.3 was signiﬁcantly less suppressed (;30%
inhibition) by cholesterol. For the high-amplitude Kir2.1 and
Kir2.2 control currents, the current amplitudes may be
FIGURE 4 Effect of cholesterol modulation on surface expression of
Kir2.1. (Aa) Typical images of Kir2.1 surface expression observed in the
middle plane of cells after cholesterol depletion, no treatment, and
cholesterol enrichment. Bar, 4 mm. (Ab) 3-D reconstruction of the cells
shown in Aa, which combines 20 optical sections taken at 300 nm apart. (B)
Quantiﬁcation of Kir2.1 surface expression at the middle plane (a) and in
3-D reconstructed images (b) of single cells. Expression levels were
determined as a function of ﬂuorescently labeled HA-Kir2.1 intensity in
cholesterol-depleted, control, and cholesterol-enriched cells (n ¼ 10 per
condition). Fluorescent intensity of each cell was normalized to its area.
There was statistically no difference in Kir2.1 surface expression at the
middle plane as well as the upper and lower sections (not shown) for each
cholesterol condition. Identical results were obtained in four independent
experiments. (C) Surface expression of Kir2.1 in a cell population was
determined as a function of luminescence using ELISA assay. In each
experiment luminescence was measured in quadruplicate for each
cholesterol condition. No statistical difference in Kir2.1 expression was
conﬁrmed in four independent experiments.
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slightly underestimated due to incomplete compensation of
the pipette series resistance, suggesting that the degree of
current suppression by cholesterol for Kir2.1 and Kir2.2 is
higher than measured. The actual difference between the
sensitivities of these channels and Kir2.3 channels to cho-
lesterol is expected, therefore, to be greater than estimated
from the recordings. Rectiﬁcation properties of none of the
channels were affected by the cholesterol treatment (not
shown).
To investigate further the difference between cholesterol
sensitivities of Kir2.1 and Kir2.3, the currents were recorded
in cells in which cholesterol was varied over the range
between 60% depletion and 40% enrichment. This was
achieved by exposing the cells to the mixture of MbCD and
MbCD-cholesterol complex at different ratios, which ef-
fectively resulted in changing the ratio between MbCD and
cholesterol. As was shown earlier (Christian et al., 1997),
this procedure allowed precise adjustment of the cellular
cholesterol to different levels (Fig. 6 A). Over this range, the
relationship between the current densities and the level of
cellular cholesterol was linear for both Kir2.1 and Kir2.3.
The slopes of the regression of the normalized data were
2.0 6 0.3 and 0.8 6 0.2 for Kir2.1 and Kir2.3,
respectively (p , 0.01), demonstrating the strong difference
in the cholesterol sensitivities of Kir2.1 and Kir2.3 channels
(Fig. 6 B). However, the inactivation properties of Kir2.1
(Fig. 2) and Kir2.3 (not shown) were similar and unaffected
by cholesterol.
Localization of Kir2.x channels in
detergent-resistant membranes
Sensitivity of the Kir2.x to cholesterol depletion suggested
that these channels might partition into lipid rafts, choles-
terol-rich detergent-resistant membrane domains. One of the
common methods used to determine whether the proteins
partition into lipid rafts is to solubilize nonlipid raft
membranes with Triton X-100 and test the distribution of
the protein between the Triton-soluble and Triton-insoluble
membrane fractions. Kir2.1, Kir2.2, and Kir2.3 almost
completely partitioned to Triton-insoluble membrane frac-
tions (the antibody for Kir2.4 was not available to us), which
contained ;25% of total membrane protein. Speciﬁcally,
Fig. 7 shows Kir2.x-speciﬁc bands in whole cell, total
membrane, and its Triton-soluble and Triton-insoluble
fractions. Each individual blot was also probed for caveolin,
FIGURE 5 The differential sensitiv-
ity of heterologous Kir2.x channels to
cholesterol enrichment. (A) Each panel
shows typical current traces recorded
from individual cells expressing the
indicated Kir2.x channel that were
either exposed to serum-free medium
(control) or to 5 mM MbCD saturated
with cholesterol. (B) Mean current
densities in cholesterol-enriched cells
normalized to respective currents in
control cells. The data were pooled
from 3–8 experimental days (*P, 0.05
compared to Kir2.1 and Kir2.2).
Modulation of Kir2.x by Cholesterol 3857
Biophysical Journal 87(6) 3850–3861
a major lipid raft marker. The distribution of Kir2.x-speciﬁc
bands between the Triton-soluble and insoluble fractions
strongly correlated with the distribution of caveolin. The
partitioning of the Kir2.x channels and of caveolin was
quantiﬁed by calculating the ratio of the band density in
Triton-insoluble fraction to the total amount of the protein in
both membrane fractions (Fig. 7 B).
DISCUSSION
Growing evidence suggest that ion channels are regulated by
their lipid environment (reviewed by Barrantes, 2002;
Hilgemann et al., 2001; Martens et al., 2004; and Tillman
and Cascio, 2003). Speciﬁcally, multiple studies demon-
strated that inwardly rectifying K1 channels are regulated by
phosphoinositides (Cukras et al., 2002; Lopes et al., 2002;
Rohacs et al., 1999; Shyng et al., 2000). In addition, it was
shown that an increase in membrane cholesterol suppresses
large conductance Ca21-sensitive K1 channels (Bolotina
et al., 1989; Chang et al., 1995) and shifts the voltage
dependence of several subtypes of voltage-gated K1
channels (Hajdu et al., 2003; Martens et al., 2000, 2001).
Our recent study showed that cholesterol also regulates
inwardly rectifying Kir current (Romanenko et al., 2002) but
the molecular identity of the cholesterol-sensitive Kir has not
been established and little was known about the mechanisms
responsible for this effect. In this study, we demonstrate that
Kir2.x channels heterologously expressed in a null cell line
are cholesterol sensitive and we investigate the mechanisms
that might be responsible for this effect. Our data suggest that
cholesterol speciﬁcally alters the activity of plasma mem-
brane Kir2 channels and modulates transitions from active to
‘‘silent’’ states of the channels.
First, we tested whether cholesterol-induced suppression
of Kir2.1 current can be accounted for by changes in the
FIGURE 6 The functional dependence of Kir2.1 and Kir2.3 currents on
the level of membrane cholesterol. (A) Cellular levels of free cholesterol in
cells exposed to mixtures with various ratios of MbCD to MbCD-
cholesterol (n ¼ 6–9, *P , 0.05). (B) Normalized peak current densities
(160 mV) were plotted as a function of normalized level of free cholesterol
in cells exposed to mixtures of 5 mMMbCD and 5 mMMbCD-cholesterol.
All peak current densities were normalized to those of control cells measured
on the same day (3–6 cells per day per condition): (:), Kir2.1; (d), Kir2.3
(n ¼ 3–10 experimental days). The data were adequately ﬁt by linear
regression analysis (r2 $ 0.99 for Kir2.1 and r2 $ 0.96 for Kir2.3).
FIGURE 7 Partitioning of heterologous Kir2.x in to Triton X-100-
insoluble membrane fraction. (A) An example of typical immunoblots
prepared from CHO cells expressing Kir2.1, Kir2.2, and Kir2.3 channels.
Caveolin was usually detected simultaneously with the individual channel on
themembrane portion that was cut below 45 kDa. The vertical lanes represent
samples prepared from whole-cell homogenates (WH), total membrane
fraction (TM), Triton-soluble (sol.) and Triton-insoluble (insol.) fractions.
The samples were loaded with the same amount of total protein. (B) The
percentage of the channel proteins and caveolin (caveol.), and total protein
(TProt.) associated with Triton-insoluble membrane fractions (n ¼ 4).
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single-channel properties, as was shown previously for
large-conductance Ca21-sensitive K1 channels in smooth
muscle cells (Bolotina et al., 1989; Chang et al., 1995). Our
observations show, however, that changes in the level of
cellular cholesterol had no effect on the unitary conductance
and only a very small effect on the open probability of Kir2.1
(;7% decrease in Po), demonstrating that changes in the
single-channel properties cannot account for cholesterol-
induced suppression of Kir2.1. These observations are
consistent with our earlier data showing no effect of
cholesterol on the single-channel properties of endogenous
Kir current in aortic endothelial cells (Romanenko
et al., 2002). It is also consistent with a lack of cholesterol
effect on the biophysical properties of the whole-cell Kir2.1
current.
Second, we tested the hypothesis that cholesterol may
suppress the expression of the channels. The rationale for
this hypothesis was that cholesterol is well-known to
regulate the expression of a variety of proteins (reviewed
by Shimano, 2001). Although it has already been shown that,
in contrast to Kir3.1 and Kir6.2, hypercholesterolemia has no
effect on Kir2.1 mRNA in smooth muscle cells (Ren et al.,
2001), the effect of cholesterol on the protein level of Kir2.1
has not been tested. It is particularly important because it is
known that mRNA levels may not necessarily precisely
reﬂect the cellular levels of the proteins (Barry et al., 1995).
Here we show that 1), sensitivity of the current to cholesterol
was retained after protein synthesis was blocked by CHX;
and 2), changes in the level of cholesterol had no apparent
effect on the level of the protein as compared by
immunoblotting, indicating that regulation of protein
expression is not responsible for the cholesterol sensitivity
of the Kir2.1 current. Taken together with the observation
that cholesterol has no effect on the single-channel properties
of the channels, these observations suggest that changes in
the level of cellular cholesterol affect the number of channels
in the plasma membrane.
Finally, we tested the possibility that changes in the level
of cholesterol affect the surface expression of the channels,
so that more channels are retained in the intracellular
membranes and fewer channels are inserted into the plasma
membrane. Indeed, cholesterol-rich membrane domains are
known to have a major impact on sorting and trafﬁcking of
the membrane proteins (for review, see Ikonen, 2001).
However, no cholesterol effect on the surface expression of
Kir2.1 channels was observed in our study indicating that
cholesterol-induced regulation of Kir2.1 is not due to the
regulation of insertion/retrieval of the channels to and from
plasma membrane. It is noteworthy that, consistent with the
lack of cholesterol effect on Kir2.1 surface expression, there
was also no effect on cell capacitance supporting our con-
clusion that downregulation of the current is not due to the
retrieval of the channels from the plasma membrane. This in-
dicates that an increase in membrane cholesterol decreases
the number of active Kir2.1 channels without decreasing the
total number of the channels in the plasma membrane. This
observation is also consistent with cholesterol having an all-
or-nothing effect on a single-channel level, whereas on the
level of the whole-cell channel population the effect is
graded. We propose, therefore, that an increase in membrane
cholesterol induces a conformation change of the channel
protein that leads to a ‘‘silent’’ (nonactive) state of the
channel. Silent channels are retained on the plasma mem-
brane but cannot be detected by single-channel analysis.
Interestingly, Kir2.1 and Kir2.2 were signiﬁcantly more
strongly inhibited by cholesterol than Kir2.3, whereas Kir2.4
had intermediate cholesterol sensitivity. This result implies
that structural differences between the channels are impor-
tant for their cholesterol sensitivity. The overall homology
between Kir2.1/Kir2.2 and Kir2.3 channels is 60–70%, and
several regulatory sites were found to be different in these
channels (Coulter et al., 1995; Zhu et al., 1999). It is also
noteworthy that Kir2.1, Kir2.2, and Kir2.3 channels were
found to partition virtually exclusively into Triton-insoluble
domains. Similar observations were reported recently for
Kir2.1 channels (Stockklausner and Klocker, 2003) and for
voltage-gated K1 channels (Martens et al., 2000, 2001). This
is the ﬁrst report that Kir2.2 and Kir2.3 partition into
detergent-resistant membrane fractions suggesting that this is
a general feature of Kir2.x subunits. Although it is known
that resistance to detergent solubilization does not automat-
ically equate to localization to lipid rafts in living cells
(Munro, 2003), the facts that all the Kir2.x subunits
partitioned to the detergent-resistant fraction and showed
functional changes induced by perturbations of membrane
cholesterol are suggestive that the sterol content in the
immediate membrane microenvironment regulates channel
activity. It is also important to note that since the channels
were observed almost exclusively in Triton-insoluble
fractions under the control conditions, it is unlikely that
cholesterol-induced suppression of the current can be due to
further partitioning of the channels into lipid raft domains.
Since alterations of sterol levels can dramatically affect the
stability of rafts (Kabouridis et al., 2000, Simons and
Toomre, 2000), we suggest that changes in the level of
cellular cholesterol alter the channel activity by modifying
the interactions of the channels with the protein or lipid
components of lipid rafts.
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